LeapFrog Leads USD55m Series D for Indian Genetic Diagnostics Company MedGenome, Sofina and Sequoia Join
Source(s): LeapFrog | MedGenome
Emerging markets impact investor LeapFrog Investments led a USD55m Series D for India-based genetic diagnostics firm MedGenome, with participation from existing investors Sofina and Sequoia Capital. Read more